Cannabinol in Austria: not individually verified

Also known as: cbn

We have not confirmed that Cannabinol specifically is scheduled in Austria, so this page gives no legal status. Publishing a guess here would be worse than publishing nothing. What we do know is the governing national drug law, below.

What is on record

Not confirmed. A definitive NPS classification of pure cannabinol could not be settled, and the difficulty is a single word in a structural definition. Group 1 of Annex II specifies reduced cannabinoid cores, the tetrahydro form at limb (g) and the hexahydro form at limb (l), whereas cannabinol is fully aromatic. Whether the word derivable stretches to cover that aromatization is the open point, and no express dehydrogenation rule settles it. The permitted substituent list does not expressly address a change in core hydrogenation either. The narcotics instrument holds no cannabinol entry, and the isomer rule cannot supply one: cannabinol has four fewer hydrogens than tetrahydrocannabinol, so it is neither a positional nor a stereo isomer of it. The psychotrope instrument holds no entry, and no prescription listing was found under either the cannabinol or the CBN spelling. A medicinal presentation could bring a particular product under the medicines act without answering the structural question, and the EU novel food regulation permits only authorised novel foods on the Union list to be marketed on that list's conditions, which controls marketing rather than classification. The public chemistry record gives the formula and connectivity and no Austrian legal interpretation.

Confirm directly with Austria’s national drug authority or your own embassy before you rely on anything.

This page is deliberately excluded from search indexing and from our sitemap. Only confirmed, individually verified statuses are published as indexable pages.